This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pulsed-field ablation (PFA) offers notable advantages in atrialfibrillation (AF) ablation by selectively targeting cardiomyocytes via an irreversible electroporation mechanism, thereby minimizing damage to surrounding tissues.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF).
The VARIPULSE Platform is comprised of the VARIPULSE Catheter, a fully integrated variable-loop multielectrode catheter; the TRUPULSE Generator, a pulsed field ablation (PFA) generator; and the CARTO 3 System VARIPULSE Software, which provides full integration with the world's leading 3D cardiac mapping system.
The increasing prevalence of atrialfibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. Emerging imaging modalities and ablation techniques might have a role to play. Journal of the American Heart Association, Ahead of Print.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillationAblation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. This is the most commonly used ablation catheter in the world for RF ablation and is fully integrated with the CARTO 3 System.
Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” have been updated with new evidence to guide clinicians.
BackgroundObesity is an important riskfactor for atrialfibrillation (AF) development and progression. Furthermore, obesity reduces health-related quality of life (HRQoL), an essential indicator for treatment efficacy of AF ablation. Heart rhythm was systematically monitored during follow-up.
This study aimed to identify the riskfactors for postoperative atrialfibrillation in patients with valvular atrialfibrillation, and establish predictive models of atrialfibrillation recurrence.
Asthma is a known riskfactor for atrialfibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
The influence of hemodynamic parameters on the recurrence of atrialfibrillation (AF) following catheter ablation is not well known, and it remains unclear whether a nomogram combining riskfactors and hemodynamic parameters improves prediction accuracy.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.
Atrialfibrillation (AF) is a progressive and degenerative disease, and its development is associated with cardiovascular riskfactors and comorbidities. There is a lack of evidence regarding the prognosis of catheter ablation in patients without any cardiovascular comorbidities.
Rate vs Rhythm Control in AtrialFibrillation Rate vs rhythm control as a management strategy in atrialfibrillation has been a long standing topic for debate. Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. Many were not in sinus rhythm or anticoagulated.
Posterior wall isolation (PWI) is an additional modality to pulmonary vein isolation (PVI) for radiofrequency ablation (RFA) for persistent atrialfibrillation (PersAF). Lack of durable PWI is a riskfactor for AF recurrence.
BackgroundThe role of anti-arrhythmic drugs (AADs) in recurrent atrialfibrillation (AF) after catheter ablation (CA) is not fully understood. ConclusionsExPVT and post-procedural high rMSSD are independent riskfactors for post-AFCA recurrence but not for AAD response in patients with recurrent AF.
Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and riskfactors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrialfibrillation (AFib) ablation in patients with heart failure with (..)
Background:Clinical studies on atrialfibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce. The identification of potential riskfactors was conducted using the regression method known as least absolute shrinkage and selection operator.
BackgroundWe assessed the impact of pre‐ and postprocedural plasma corin levels on the recurrence of atrialfibrillation (AF) after catheter ablation (CA).Methods The primary end point was recurrent AF between 3 and 12 months after ablation. pg/mL) increased the risk of recurrent AF by 54.3%
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. Maintain a Healthy Weight – Excess weight is a major riskfactor for AFib. The post How to Prevent an AtrialFibrillation Attack appeared first on AMS Cardiology.
Abstract Introduction Earlier studies have shown a clear association between severity of human immunodeficiency virus (HIV) infection and incident atrialfibrillation (AF). We present the long-term outcome of catheter ablation (CA) and electrophysiological characteristics in HIV+ AF patients. vs. 54%, p < .001],
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
Abstract Introduction Cather ablation (CA) is a well-recognized treatment alternative for atrialfibrillation (AF) patients despite more than 20% ablation-treated patients suffering from AF recurrence. The high DC postablation was a riskfactor for AF recurrence in ablation-treated patients (OR, 2.17; 95% CI, 1.44–3.25;
Nature Reviews Cardiology, Published online: 25 April 2024; doi:10.1038/s41569-024-01036-8 Treatment for periodontal disease might reduce the recurrence of atrialfibrillation (AF) in patients undergoing ablation, suggesting that periodontitis is a modifiable riskfactor for AF.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
A notched P wave is also known to predict atrialfibrillation (AF) after catheter ablation. A notched P wave is usually defined as a dip over the smallest unit of electrocardiography (ECG) recording paper, 40 ms, but automated analysis of ECGs has shown that even a notch of 20 ms is associated with cardiovascular events.
The ACC and the American Heart Association (AHA) guideline for the management of atrialfibrillation (AFib) provides a comprehensive multi-society update, the first in a decade, and offers a new staging system for AFib, upgrades recommendations for catheter ablation, rhythm control and left atrial appendage occlusion (LAAO), and emphasizes the importance (..)
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
AF, atrialfibrillation; ICD, implantable cardioverter defibrillator; ILR, implantable loop recorder. vs. 1.3%; p =0.996) or catheter ablation (3.8% Conclusion Advanced age is a significant riskfactor for clinical intervention after ILR insertion. The mean age was 64.3 vs. 18.6%; p <0.001). vs. 6.0%; p =0.512).
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
AF stands for atrialfibrillation. The big risk of AF is thought to be an increased risk of strokes and therefore when we see patients above the age of 65, or patients who carry comorbidities we recommend lifelong anticoagulation and as long as the patient is anticoagulated, we feel that the patient is safe.
Patients with iCS were more likely to have a history of atrialfibrillation (AF) or hospitalization for heart failure (HF), or lower left ventricular ejection fraction (LVEF) than those with systemic cardiac sarcoidosis. During a median follow-up of 42.3 interquartile range, 22.8–72.5) months, 141 primary outcomes (29.7%) occurred.
Diagnosis : Atrial flutter with 1:1 conduction, with fast AV conduction made possible by sympathetic drive of exercise On arrival, we obtained another 12-lead: Unremarkable Further history: One month history of shortness of breath on exertion, denies palpitations, chest pain, orthopnea, leg swelling. He underwent ablation in the EP Lab.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF).
BackgroundPrevious studies have shown that frailty increases the risk of newonset atrialfibrillation (AF). However, little is known about the association between frailty and the recurrence of AF after radiofrequency ablation. Frailty index may be a novel riskfactor of recurrent AF. versus 87.5%).
BACKGROUND:Patients undergoing first-time atrialfibrillation (AF) ablation can benefit from targeting non-pulmonary vein (PV) triggers. Preprocedural identification of high-risk individuals can guide planning of ablation strategy. Among all first-time AF ablations, 68.1% were intermediate-risk (score 2, 10.5%
Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations The Annals of Thoracic Surgery January 2022 David Shahian Social RiskFactors in Society of Thoracic Surgeons Risk Models.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
BackgroundLeft atrial appendage occlusion (LAAO) serves as an alternative to oral anticoagulation (OAC) for atrialfibrillation (AF) patients at high risk of bleeding. Persistent AF and SCr were significant riskfactors for incomplete occlusion and PDL. in the RFCA combined with the LAAO group.
BackgroundEpicardial adipose tissue (EAT) remodeling is associated with atrialfibrillation (AF). However, there is limited research on the contribution of EAT to the risk of AF recurrence (AFR). The clinical, atrial, and EAT characteristics of patients with and without AFR were compared.
Atrialfibrillation: Think locally act globally It is clear, except in specific situations like HT, LVH, HFpEF, and other left (or right )sided structural heart diseases, the bulk of the AF is part of systemic destabilization of neuro-metabolic homeostasis. Of-course ,the final denominator is atrial stress. J Atr Fibrillation.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content